Here, we assessed the impact of tumor-derived CSF1 by developing CSF1 CRISPR-Cas9 knockouts in the 4T1 mammary carcinoma and MC38 murine colon carcinoma cell lines, where mice harboring these tumors achieved tumor control when compared to the parental tumors. The gene discussed is CSF1; the disease is colon carcinoma.